Original Article
Oral Alitretinoin in the Treatment of Severe Refractory Chronic Hand Eczema in the Spanish National Health System: Description and Analysis of Current Clinical Practice
Uso de la alitretinoína oral para el tratamiento del eczema crónico de manos grave y refractario al tratamiento en el sistema sanitario público español: descripción y análisis de la práctica clínica actual
Read
7595
Timeswas read the article
2257
Total PDF
5338
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 37 | 1 | 38 |
| 2025 10 | 236 | 69 | 305 |
| 2025 9 | 147 | 55 | 202 |
| 2025 8 | 200 | 34 | 234 |
| 2025 7 | 232 | 24 | 256 |
| 2025 6 | 112 | 24 | 136 |
| 2025 5 | 194 | 44 | 238 |
| 2025 4 | 152 | 27 | 179 |
| 2025 3 | 133 | 21 | 154 |
| 2025 2 | 159 | 35 | 194 |
| 2025 1 | 89 | 30 | 119 |
| 2024 12 | 75 | 21 | 96 |
| 2024 11 | 102 | 71 | 173 |
| 2024 10 | 75 | 49 | 124 |
| 2024 9 | 94 | 25 | 119 |
| 2024 8 | 117 | 55 | 172 |
| 2024 7 | 89 | 35 | 124 |
| 2024 6 | 83 | 45 | 128 |
| 2024 5 | 91 | 43 | 134 |
| 2024 4 | 95 | 23 | 118 |
| 2024 3 | 124 | 28 | 152 |
| 2024 2 | 83 | 37 | 120 |
| 2024 1 | 109 | 31 | 140 |
| 2023 12 | 109 | 22 | 131 |
| 2023 11 | 109 | 29 | 138 |
| 2023 10 | 116 | 19 | 135 |
| 2023 9 | 91 | 33 | 124 |
| 2023 8 | 37 | 10 | 47 |
| 2023 7 | 52 | 37 | 89 |
| 2023 6 | 69 | 28 | 97 |
| 2023 5 | 68 | 22 | 90 |
| 2023 4 | 67 | 17 | 84 |
| 2023 3 | 54 | 23 | 77 |
| 2023 2 | 43 | 15 | 58 |
| 2023 1 | 45 | 25 | 70 |
| 2022 12 | 60 | 46 | 106 |
| 2022 11 | 23 | 29 | 52 |
| 2022 10 | 21 | 17 | 38 |
| 2022 9 | 51 | 47 | 98 |
| 2022 8 | 38 | 29 | 67 |
| 2022 7 | 19 | 36 | 55 |
| 2022 6 | 23 | 21 | 44 |
| 2022 5 | 33 | 34 | 67 |
| 2022 4 | 47 | 36 | 83 |
| 2022 3 | 49 | 37 | 86 |
| 2022 2 | 53 | 26 | 79 |
| 2022 1 | 39 | 37 | 76 |
| 2021 12 | 26 | 32 | 58 |
| 2021 11 | 31 | 41 | 72 |
| 2021 10 | 44 | 43 | 87 |
| 2021 9 | 34 | 29 | 63 |
| 2021 8 | 38 | 31 | 69 |
| 2021 7 | 23 | 26 | 49 |
| 2021 6 | 30 | 30 | 60 |
| 2021 5 | 24 | 39 | 63 |
| 2021 4 | 32 | 48 | 80 |
| 2021 3 | 56 | 29 | 85 |
| 2021 2 | 46 | 37 | 83 |
| 2021 1 | 34 | 21 | 55 |
| 2020 12 | 24 | 19 | 43 |
| 2020 11 | 36 | 27 | 63 |
| 2020 10 | 38 | 13 | 51 |
| 2020 9 | 34 | 11 | 45 |
| 2020 8 | 28 | 13 | 41 |
| 2020 7 | 29 | 14 | 43 |
| 2020 6 | 43 | 29 | 72 |
| 2020 5 | 28 | 22 | 50 |
| 2020 4 | 28 | 12 | 40 |
| 2020 3 | 31 | 17 | 48 |
| 2020 2 | 6 | 1 | 7 |
| 2019 12 | 4 | 0 | 4 |
| 2019 9 | 5 | 0 | 5 |
| 2019 8 | 3 | 0 | 3 |
| 2019 6 | 2 | 0 | 2 |
| 2019 5 | 0 | 1 | 1 |
| 2019 4 | 0 | 1 | 1 |
| 2019 3 | 2 | 4 | 6 |
| 2019 2 | 3 | 0 | 3 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 6 | 0 | 6 |
| 2018 11 | 5 | 0 | 5 |
| 2018 10 | 14 | 0 | 14 |
| 2018 9 | 10 | 0 | 10 |
| 2018 3 | 2 | 2 | 4 |
| 2018 2 | 26 | 4 | 30 |
| 2018 1 | 27 | 7 | 34 |
| 2017 12 | 28 | 10 | 38 |
| 2017 11 | 26 | 3 | 29 |
| 2017 10 | 24 | 6 | 30 |
| 2017 9 | 16 | 11 | 27 |
| 2017 8 | 22 | 6 | 28 |
| 2017 7 | 19 | 9 | 28 |
| 2017 6 | 30 | 10 | 40 |
| 2017 5 | 34 | 5 | 39 |
| 2017 4 | 19 | 10 | 29 |
| 2017 3 | 14 | 9 | 23 |
| 2017 2 | 14 | 8 | 22 |
| 2017 1 | 14 | 6 | 20 |
| 2016 12 | 25 | 17 | 42 |
| 2016 11 | 23 | 15 | 38 |
| 2016 10 | 33 | 22 | 55 |
| 2016 5 | 0 | 5 | 5 |
Show all
